KRT7 was higher in chRCC (both RNA and protein levels), markers such as KIT and FOXI1 were equally expressed in ROs and chRCC, while CCND1 overexpression was specific to fusion-positive RO (Figure S7A). The gene discussed is FOXI1; the disease is chromophobe renal cell carcinoma.